Met Life Investment Management, LLC Oric Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 36,078 shares of ORIC stock, worth $308,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,078
Previous 36,078 -0.0%
Holding current value
$308,466
Previous $255,000 44.71%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$6.63 - $12.93 $101,710 - $198,359
15,341 Added 73.98%
36,078 $255,000
Q1 2024

May 14, 2024
BUY
$8.04 - $16.03 $166,725 - $332,414
20,737 New
20,737 $285,000
Q3 2023

May 09, 2024
BUY
$6.05 - $9.28 $125,458 - $192,439
20,737 New
20,737 $125,000
Q2 2023

Apr 29, 2024
BUY
$4.95 - $8.4 $102,648 - $174,190
20,737 New
20,737 $160,000
Q2 2023

Aug 10, 2023
BUY
$4.95 - $8.4 $102,648 - $174,190
20,737 New
20,737 $160,000
Q1 2022

May 12, 2022
SELL
$4.54 - $16.1 $51,379 - $182,203
-11,317 Closed
0 $0
Q4 2021

Jun 21, 2023
BUY
$12.01 - $20.3 $135,917 - $229,735
11,317 New
11,317 $166,000
Q3 2021

May 17, 2024
BUY
$15.9 - $25.22 $29,669 - $47,060
1,866 Added 19.74%
11,317 $236,000
Q3 2021

Jun 21, 2023
BUY
$15.9 - $25.22 $179,940 - $285,414
11,317 New
11,317 $236,000
Q3 2021

Mar 22, 2023
BUY
$15.9 - $25.22 $29,669 - $47,060
1,866 Added 19.74%
11,317 $236,000
Q3 2021

Nov 15, 2021
BUY
$15.9 - $25.22 $29,669 - $47,060
1,866 Added 19.74%
11,317 $237,000
Q2 2021

Jun 21, 2023
BUY
$17.37 - $25.34 $164,163 - $239,488
9,451 New
9,451 $167,000
Q1 2021

May 17, 2024
SELL
$23.67 - $36.85 $267,139 - $415,889
-11,286 Reduced 54.42%
9,451 $231,000
Q1 2021

Jun 26, 2023
BUY
$23.67 - $36.85 $223,705 - $348,269
9,451 New
9,451 $232 Million
Q4 2020

May 24, 2024
BUY
$20.32 - $39.8 $98,267 - $192,472
4,836 Added 104.79%
9,451 $319,000
Q4 2020

Jun 22, 2023
BUY
$20.32 - $39.8 $192,044 - $376,149
9,451 New
9,451 $319,000
Q4 2020

Mar 22, 2023
BUY
$20.32 - $39.8 $98,267 - $192,472
4,836 Added 104.79%
9,451 $319,000
Q4 2020

Feb 16, 2021
BUY
$20.32 - $39.8 $192,044 - $376,149
9,451 New
9,451 $320,000
Q3 2020

Nov 13, 2020
SELL
$19.5 - $31.26 $89,992 - $144,264
-4,615 Closed
0 $0
Q2 2020

May 24, 2024
SELL
$25.68 - $38.12 $414,012 - $614,570
-16,122 Reduced 77.75%
4,615 $156 Million
Q2 2020

Jun 26, 2023
BUY
$25.68 - $38.12 $118,513 - $175,923
4,615 New
4,615 $155,000
Q2 2020

Mar 22, 2023
BUY
$25.68 - $38.12 $118,513 - $175,923
4,615 New
4,615 $155,000
Q2 2020

Aug 14, 2020
BUY
$25.68 - $38.12 $118,513 - $175,923
4,615 New
4,615 $156,000

Others Institutions Holding ORIC

# of Institutions
125
Shares Held
66.6M
Call Options Held
7.8K
Put Options Held
700
View Full List

About Oric Pharmaceuticals, Inc.

ORIC Quotes by TradingView
  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $338M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email